Sitkovsky, M. V., Hatfield, S., Abbott, R., Belikoff, B., Lukashev, D., & Ohta, A. (2014). Hostile, Hypoxia-A2-Adenosinergic Tumor Biology as the Next Barrier to the Tumor Immunologists. Cancer Immunol Res.
Chicago-stil citatSitkovsky, Michail V., Stephen Hatfield, Robert Abbott, Bryan Belikoff, Dmitry Lukashev, och Akio Ohta. "Hostile, Hypoxia-A2-Adenosinergic Tumor Biology As the Next Barrier to the Tumor Immunologists." Cancer Immunol Res 2014.
MLA-referensSitkovsky, Michail V., et al. "Hostile, Hypoxia-A2-Adenosinergic Tumor Biology As the Next Barrier to the Tumor Immunologists." Cancer Immunol Res 2014.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.